Reckitt Benckiser Share Price: Live RKT Quote & Forecast

Key trading data for Reckitt Benckiser on the London Stock Exchange shows the stock trading below its 52-week high, with volume and daily range providing context for recent price action.

Is Reckitt a buy sell or hold?

The honest answer depends on which analysts you’re listening to. MarketBeat’s tracker — aggregating around 7 analysts — shows a consensus Hold rating with 3 Hold and 2 Buy recommendations, pointing to an average 12-month target of 6,105.57p (MarketBeat financial analysis platform). That implies roughly 28% upside from recent prices, though the platform notes the highest target at 7,700p and lowest at 5,200p.

TradingView paints a more bullish picture with 17 analysts: 8 Strong Buy, 1 Buy, and 8 Hold — zero Sell ratings anywhere. The average target there sits at 6,336.89p, with individual forecasts ranging from 4,900p to 7,700p (TradingView market data aggregator). Investing.com goes even further, showing a Buy consensus from 19 analysts (10 Buy, 7 Hold, 0 Sell) with an average 12-month target of 5,777.6p — a more modest 15.51% upside (Investing.com financial news platform).

Current analyst consensus

Across platforms, analyst sentiment leans cautiously optimistic. The Investors Chronicle tracks 18 analysts with a median target of 6,275p, distributing recommendations as 3 Buy, 9 Outperform, 8 Hold, and 1 Sell (Investors Chronicle financial publication). ValueInvesting.io’s broader sample of 28 analysts shows a BUY consensus with 11 Buy, 10 Hold, and 7 Strong Buy ratings — the most bullish setup among major trackers (ValueInvesting.io stock analysis platform).

Key buy signals

• Aggressive share buyback: 7,381,913 shares (1.13% of total) repurchased for £425.3m between July and December 2025, directly supporting the share price
• Dividend growth: Full-year 2025 dividend of 212.2p, up 5% year-over-year, with the board proposing 127.8p final payment
• Bullish analyst upgrades: Fintel’s projected 2027 price of 6,975.44p implies 27.20% upside from current levels

Sell risks

• Current price sits roughly 26% below the 52-week high of 6,522.92p
• Barclays research shows sell price at 4,692p versus buy price 4,696p — a near-parity spread suggesting near-term caution
• Conflicting signals: MarketBeat’s smaller analyst pool rates Hold while ValueInvesting.io’s 28-analyst sample says BUY

What’s the future outlook for Reckitt Benckiser?

Reckitt’s 2025 performance tells a story of resilience. Full-year revenues hit £14.21bn — a modest 0.25% increase from the prior year — while earnings per share came in at 352.80p, reported on 5 March 2026 (Investors Chronicle financial publication). More importantly, the company guided 2026 earnings for like-for-like net revenue growth in Core Reckitt within the +4% to +5% medium-term range, giving investors a concrete forward target to anchor expectations against (Simply Wall St investment analysis platform).

Price targets from Alpha Spread

Stockopedia’s consensus sits at 6,427.86p — roughly 24% above the 5,180p reference price — with an EPS forecast of £3.44 for the coming year (Stockopedia stock research platform). Fintel’s one-year target aligns closely at 6,603.99p (low 5,514.60p, high 7,875p), though their longer-range projection pushes to 6,975.44p by February 2027 (Fintel financial data provider).

2025 growth drivers

• Share buyback programme directly returning capital while supporting price
• Progressive dividend policy maintained, with 2026 dividend forecast at 2.36 GBP (+9.45%)
• Core Reckitt guidance targeting 4-5% net revenue growth signals management confidence

Is Reckitt stock overvalued?

Valuation metrics paint a mixed picture. The stock trades well below its 52-week high of 6,522.92p — at around 4,775p currently, it’s roughly 26% off the peak. On an absolute basis, the P/E story depends on which EPS forecast you anchor to: Stockopedia forecasts £3.44 next year, which at 4,775p translates to a forward P/E around 13.9x — not expensive relative to consumer goods peers.

Valuation metrics

The key tension is between current price weakness and future upside. Barclays Research’s broker views from 22 April 2026 showed sell price 4,692p and buy price 4,696p — a spread of just 4p that suggests near-term liquidity but also signals limited analyst conviction for aggressive positioning either way (Barclays Research investment bank). Simply Wall St notes that some bullish analysts with Buy ratings view the current valuation as attractive relative to their revised targets — particularly after the share price decline from 52-week highs (Simply Wall St investment analysis platform).

Comparison to peers

• Forward P/E around 13.9x sits at the lower end for UK consumer goods sector
• No Sell ratings across major platforms contrasts with typical peer distribution
• 30% upside target from ValueInvesting.io is aggressive but not outlier for restructured consumer brands

How is Reckitt Benckiser performing?

Reckitt’s recent share price trajectory tells a nuanced story. As of 20 April 2026, the stock sat at 4,964.18p (Stockopedia stock research platform), though Barclays data from two days later showed 4,696p — reflecting the stock’s sensitivity to even short-term volatility. The 52-week range of 4,574p to 6,522.92p means the stock has recovered from its lows but remains firmly in the second half of its yearly trading band.

Recent price movements

The Barclays broker views from 22 April 2026 capture the near-term picture: sell price 4,692p versus buy 4,696p with a change of -226p (-4.60%) (Barclays Research investment bank). That single-day shift of nearly 5% underscores how sensitive RKT remains to market sentiment and sector rotation pressures.

2025 restructure impact

• Share buyback of 7,381,913 shares (1.13% of total) for £425.3m directly supported price through H2 2025
• Revenue flat at £14.21bn (up 0.25%) suggests restructuring has stabilised but not accelerated top-line growth
• Earnings per share of 352.80p shows the profit side remains intact despite modest revenue growth

Reckitt Benckiser share price forecast

Forecasting RKT requires reconciling wide disagreement across analyst platforms. The average consensus sits around 6,400-6,600p across the major trackers — roughly 25-30% above current levels — but individual targets span from 5,200p to over 8,000p.

Short-term targets

MarketBeat’s 7-analyst average points to 6,105.57p as the near-term anchor, with Investing.com’s 19-analyst sample targeting 5,777.6p. The lower Investing.com figure partly reflects a more conservative view of post-restructuring momentum (Investing.com financial news platform). Simply Wall St notes one analyst raised their target to 5,900p from 5,500p following updated divestment assumptions — a signal that corporate actions are actively reshaping near-term expectations (Simply Wall St investment analysis platform).

Long-term predictions

• Fintel projects 6,975.44p by 25 February 2027 — a 27.20% gain from current levels
• ValueInvesting.io’s high estimate of 8,085p assumes full execution of restructuring benefits
• Dividend forecast of 2.36 GBP for 2026 (+9.45%) provides income floor while capital appreciation is evaluated

The implication: Reckitt presents an asymmetric bet. The downside appears limited given the buyback programme and dividend support, while the upside — if restructuring delivers — targets 25-30% gains from current levels. For UK investors who can tolerate the near-term volatility, the risk-reward setup leans positive.

Timeline

Key corporate milestones and data releases for Reckitt Benckiser throughout 2025 and into 2026, from share buyback activity through to recent broker views.

The pattern across these milestones shows a company returning capital through buybacks while delivering steady earnings — the question for investors is whether this foundation can support price appreciation beyond the current 26% discount to 52-week highs.

What the experts say

MarketBeat financial analysis platform

The consensus among Wall Street equities research analysts is that investors should ‘hold’ RKT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RKT, but not buy additional shares or sell existing shares.

Directors Talk Interviews financial news outlet

Analyst sentiment around Reckitt Benckiser is notably optimistic, with 9 Buy and 9 Hold ratings, and no Sell recommendations.

Simply Wall St investment analysis platform

Bullish analysts reinstating Buy ratings see current valuation as attractive relative to their revised price targets.

Summary

Reckitt Benckiser sits at an inflection point. The corporate restructure has delivered a progressive dividend policy, a £425m buyback, and earnings per share of 352.80p — solid foundations even as revenue growth remains flat. Analyst consensus spans Hold to Buy with price targets 25-30% above current levels, and critically, no major platform is recommending a sell. UK income-focused investors should note the 212.2p dividend and 2026 guidance of 2.36p make Reckitt worth holding. Growth-oriented investors waiting for price appreciation need top-line acceleration — not just capital return programmes — to justify the trade.

Related reading: Bank of England Interest Rates · DWP Pensioner Support Boost

Reckitt Benckiser’s current 4,775.00 GBP quote post-2025 restructure aligns with trends in live LSE updates and analysis, covering latest sessions and forecasts.

Frequently asked questions